Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA LBW242 CCLE pan-cancer AAC -0.021 0.7
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA KIN001-260 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA Panobinostat FIMM pan-cancer AAC -0.051 0.7
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Irinotecan CCLE pan-cancer AAC 0.023 0.7
mRNA ML083 CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV